Literature DB >> 1328137

Rifabutin treatment for tuberculosis patients with liver function abnormalities.

P Mancini, F Pasqua, L Mazzei, P Olliaro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1328137     DOI： 10.1093/jac/30.2.242

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Experience with rifabutin replacing rifampin in the treatment of tuberculosis.

Authors:  D J Horne; C Spitters; M Narita
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

Review 2.  Tuberculosis and HIV infection: a review.

Authors:  D Schürmann; S D Nightingale; F Bergmann; B Ruf
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 7.455

Review 3.  Clinical pharmacokinetics of rifabutin.

Authors:  M H Skinner; T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 4.  Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; A Fitton
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.